Category Archive: Finance
Regeneron/Sanofi’s Dupixent Asthma Study Meets Endpoints
Regeneron Pharmaceuticals, Inc. (REGN – Free Report) and partner Sanofi (SNY – Free Report) announced that Dupixent (dupilumab) met its two primary endpoints in a phase III study conducted on patients with uncontrolled, persistent asthma. Data from the LIBERTY ASTHMA QUEST study showed that Dupixent, when added to standard therapies, reduced severe asthma attacks and improved lung function. Shares of […]
Dollar Index Bounces From 33-Month Low, Risk In Vogue As JPY Sells Off
What a day for risk. USD/JPY rallied aggressively after trading at a 2017 low on Friday and the S&P 500 rose the most since April to close at all-time highs. Other risk-off markets like Gold gapped lower on the open and the US Treasury 10-year yield also bounced showing investors wanted risk over a fixed return. Things look good, at least […]
AUD: How High Can The Currency Down Under Go?
The Australian dollar reached new highs and seems more confident above 0.80. Where next? Is the bull trend in tact? Here is their view, courtesy of eFXnews: AUD/USD: Allow For S/T Selling Before Resuming Of Core Bull Trend: Levels & Targets – Credit Suisse Credit Suisse FX Technical Strategy Research notes that AUD/USD has held […]
P&G Moves Higher Amid Back And Forth Between Company And Activist Peltz
Shares of consumer goods giant Procter & Gamble (PG) are up after Nelson Peltz and his Trian Fund spoke earlier at an investor conference to discuss the white paper that Trian released last week. TRIAN’S WHITE PAPER: On September 6, activist investor Trian, which has significant investments in General Electric Company (GE), Mondelez (MDLZ), BNY […]
Breadth Lagging New Highs
Below is a chart of the S&P 500-tracking SPY ETF from our Interactive Chart Tool platform (use it for free at any time here). If current prices hold, the S&P will make a new all-time closing high today…eclipsing highs last made in early August. We’ve been covering underlying market breadth quite a bit over the last few […]
ETF Watchlist: Week Of September 11, 2017
In doing some research this past week, I came upon a thread encouraging readers to talk about their worst investment or stock trade they’ve ever been a part of. It was a fascinating read that reminded me of the one thing that most people don’t feel like talking about. And that is that everybody has […]
Who’s Happy With Their Yen Short?
Ok, well if you wanted to look at just one thing to gauge sentiment on Monday, USD/JPY would probably be just as good a choice as anything. Between the rebound in Treasury yields and the evaporation of the safe haven bid, multiple factors are weighing on the yen and USD/JPY is set for its biggest […]
August 2017 Consumer Expectations: Show Mainly Stable Outlook
from the New York Fed Results from the August 2017 Survey of Consumer Expectations show a mainly stable outlook. Inflation expectations were unchanged at the one-year horizon and decreased slightly at the three-year horizon. Employment and wage growth expectations signal continued strength of the labor market, while consumers’ expectations of year-ahead increases in taxes continue to rise. […]
For Stocks, Diagnoses Come Before Prescriptions
Been to a doctor lately? Did your doc order a slate of tests to diagnose your condition? Physicians aren’t the only ones concerned with analytic assays. Economists, for example, have been fretting over the so-called “Trump Bump” that developed last November: Is it a permanent condition or merely a temporary lesion that will resolve itself […]
Will The Central Bank Party Continue? One Trader Notes “It’s Always Flow, Not Stock, That Matters”
Last week, former fund manager Rich Breslow made it clear that “the only thing standing between this being full-blown panic versus the frenetic gyrations we’re seeing is the central bank put.” He is, of course, correct. One glimpse at the following chart tells you all you need to know about ‘trading’ in these ‘markets’. However, as Breslow […]
